Chronic Obstructive Pulmonary Disease and Stroke

References

• Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–128. doi:10.1016/S0140-6736(12)61728-0. PMID:23245604.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997;349(9064):1498–504. doi:10.1016/S0140-6736(96)07492-2. PMID:9167458.
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–82. doi:10.1164/rccm.201701-0218PP. PMID:28128970.
   PubMed Web of Science ®Google Scholar
• Corlateanu A, Covantev S, Mathioudakis AG, Botnaru V, Siafakas N. Prevalence and burden of comorbidities in chronic obstructive pulmonary disease. Respir Investig. 2016;54(6):387–96. doi:10.1016/j.resinv.2016.07.001. PMID:27886849.
   PubMed Web of Science ®Google Scholar
• Fumagalli G, Fabiani F, Forte S, Napolitano M, Balzano G, Bonini M, De Simone G, Fuschillo S, Pentassuglia A, Pasqua F, et al. INDACO project: COPD and link between comorbidities, lung function and inhalation therapy. Multidiscip Respir Med. 2015;10(1):4. doi:10.1186/2049-6958-10-4. PMID:25973198.
   PubMedGoogle Scholar
• Feigin VL, Krishnamurthi R, Parmar P, Norrving B, Mensah GA, Bennett DA, Barker-Collo S, Moran A, Sacco RL, Truelsen T, et al. Update on the global burden of ischaemic and haemorrhagic stroke in 1990–2013: the GBD 2013 study. Neuroepidemiology. 2015;45(3):161–76. doi:10.1159/000441085. PMID:26505981.
   PubMed Web of Science ®Google Scholar
• de Lucas-Ramos P, Izquierdo-Alonso JL, Moro JMR-G, Frances JF, Lozano PV, Bellón-Cano JM, group Cs. Chronic obstructive pulmonary disease as a cardiovascular risk factor: results of a case–control study (CONSISTE study). Int J Chron Obstruct Pulmon Dis. 2012;7:679–86. PMID:23055717.
   PubMed Web of Science ®Google Scholar
• Rothnie KJ, Yan R, Smeeth L, Quint JK. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open. 2015;5(9):e007824. doi:10.1136/bmjopen-2015-007824. PMID:26362660.
   PubMed Web of Science ®Google Scholar
• Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E, Jr., She D. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16(1):63–70. doi:10.1016/j.annepidem.2005.04.008. PMID:16039877.
   PubMed Web of Science ®Google Scholar
• Lekoubou A, Ovbiagele B. Prevalance and influence of chronic obstructive pulmonary disease on stroke outcomes in hospitalized stroke patients. eNeurologicalSci. 2017;6:21–4. doi:10.1016/j.ensci.2016.11.007. PMID:28018982.
   PubMedGoogle Scholar
• Soderholm M, Inghammar M, Hedblad B, Egesten A, Engstrom G. Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease. Eur J Epidemiol. 2016;31(2):159–68. doi:10.1007/s10654-015-0113-7. PMID:26711630.
   PubMed Web of Science ®Google Scholar
• Balofsky A, George J, Papadakos P. Neuropulmonology. Handb Clin Neurol. 2017;140:33–48. doi:10.1016/B978-0-444-63600-3.00003-9. PMID:28187807.
   PubMedGoogle Scholar
• Arboix A, Morcillo C, Garcia-Eroles L, Oliveres M, Massons J, Targa C. Different vascular risk factor profiles in ischemic stroke subtypes: a study from the “Sagrat cor hospital of barcelona stroke registry.” Acta Neurol Scand. 2000;102(4):264–70. doi:10.1034/j.1600-0404.2000.102004264.x. PMID:11071113.
   PubMed Web of Science ®Google Scholar
• O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112–23. doi:10.1016/S0140-6736(10)60834-3. PMID:20561675.
   PubMed Web of Science ®Google Scholar
• Portegies ML, Lahousse L, Joos GF, Hofman A, Koudstaal PJ, Stricker BH, Brusselle GG, Ikram MA. Chronic obstructive pulmonary disease and the risk of stroke. the rotterdam study. Am J Respir Crit Care Med. 2016;193(3):251–8. doi:10.1164/rccm.201505-0962OC. PMID:26414484.
   PubMed Web of Science ®Google Scholar
• Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65(11):956–62. doi:10.1136/thx.2009.128082. PMID:20871122.
   PubMed Web of Science ®Google Scholar
• Lund Haheim L, Holme I, Hjermann I, Tonstad S. Risk-factor profile for the incidence of subarachnoid and intracerebral haemorrhage, cerebral infarction, and unspecified stroke during 21 years' follow-up in men. Scand J Public Health. 2006;34(6):589–97. doi:10.1080/14034940600731523. PMID:17132592.
   PubMed Web of Science ®Google Scholar
• Austin V, Crack Peter J, Bozinovski S, Miller Alyson A, Vlahos R. COPD and stroke: are systemic inflammation and oxidative stress the missing links? Clin Sci. 2016;130(13):1039–50. doi:10.1042/CS20160043. PMID:27215677.
   PubMed Web of Science ®Google Scholar
• Dziedzic T. Systemic inflammation as a therapeutic target in acute ischemic stroke. Expert Rev Neurother. 2015;15(5):523–31. doi:10.1586/14737175.2015.1035712. PMID:25865856.
   PubMed Web of Science ®Google Scholar
• Denes A, Ferenczi S, Kovacs KJ. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size. J Neuroinflammation. 2011;8:164. doi:10.1186/1742-2094-8-164. PMID:22114895.
   PubMed Web of Science ®Google Scholar
• McColl BW, Rothwell NJ, Allan SM. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci. 2008;28(38):9451–62. doi:10.1523/JNEUROSCI.2674-08.2008. PMID:18799677.
   PubMed Web of Science ®Google Scholar
• Kleinig TJ, Vink R. Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options. Curr Opin Neurol. 2009;22(3):294–301. doi:10.1097/WCO.0b013e32832b4db3. PMID:19434798.
   PubMed Web of Science ®Google Scholar
• Ferdinand P, Roffe C. Hypoxia after stroke: a review of experimental and clinical evidence. Exp Transl Stroke Med. 2016;8:9. doi:10.1186/s13231-016-0023-0. PMID:27980710.
   PubMedGoogle Scholar
• Roffe C, Ali K, Warusevitane A, Sills S, Pountain S, Allen M, Hodsoll J, Lally F, Jones P, Crome P. The SOS pilot study: a RCT of routine oxygen supplementation early after acute stroke–effect on recovery of neurological function at one week. PLoS One. 2011;6(5):e19113. doi:10.1371/journal.pone.0019113. PMID:21625533.
   PubMed Web of Science ®Google Scholar
• Ali K, Warusevitane A, Lally F, Sim J, Sills S, Pountain S, Nevatte T, Allen M, Roffe C. The stroke oxygen pilot study: a randomized controlled trial of the effects of routine oxygen supplementation early after acute stroke–effect on key outcomes at six months. PLoS One. 2014;8(6):e59274. doi:10.1371/journal.pone.0059274. PMID:23755093.
   PubMed Web of Science ®Google Scholar
• Roffe C, Sills S, Pountain SJ, Allen M. A randomized controlled trial of the effect of fixed-dose routine nocturnal oxygen supplementation on oxygen saturation in patients with acute stroke. J Stroke Cerebrovasc Dis. 2010;19(1):29–35. doi:10.1016/j.jstrokecerebrovasdis.2009.02.008. PMID:20123224.
   PubMed Web of Science ®Google Scholar
• De Reuck J, Proot P, Van Maele G. Chronic obstructive pulmonary disease as a risk factor for stroke-related seizures. Eur J Neurol. 2007;14(9):989–92. doi:10.1111/j.1468-1331.2007.01829.x. PMID:17718690.
   PubMed Web of Science ®Google Scholar
• Tregub P, Kulikov V, Motin Y, Bespalov A, Osipov I. Combined exposure to hypercapnia and hypoxia provides its maximum neuroprotective effect during focal ischemic injury in the brain. J Stroke Cerebrovasc Dis. 2015;24(2):381–7. doi:10.1016/j.jstrokecerebrovasdis.2014.09.003. PMID:25498739.
   PubMed Web of Science ®Google Scholar
• Westermaier T, Stetter C, Kunze E, Willner N, Holzmeier J, Kilgenstein C, Lee JY, Ernestus RI, Roewer N, Muellenbach RM. Controlled transient hypercapnia: a novel approach for the treatment of delayed cerebral ischemia after subarachnoid hemorrhage? J Neurosurg. 2014;121(5):1056–62. doi:10.3171/2014.7.JNS132611. PMID:25148012.
   PubMed Web of Science ®Google Scholar
• Icme F, Erel O, Avci A, Satar S, Gulen M, Acehan S. The relation between oxidative stress parameters, ischemic stroke, and hemorrhagic stroke. Turk J Med Sci. 2015;45(4):947–53. doi:10.3906/sag-1402-96. PMID:26422872.
   PubMed Web of Science ®Google Scholar
• Milanlioglu A, Aslan M, Ozkol H, Cilingir V, Nuri Aydin M, Karadas S. Serum antioxidant enzymes activities and oxidative stress levels in patients with acute ischemic stroke: influence on neurological status and outcome. Wien Klin Wochenschr. 2016;128(5-6):169–74. doi:10.1007/s00508-015-0742-6. PMID:25854910.
   PubMed Web of Science ®Google Scholar
• Kleinschnitz C, Grund H, Wingler K, Armitage ME, Jones E, Mittal M, Barit D, Schwarz T, Geis C, Kraft P, et al. Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol. 2010;8(9). doi:10.1371/journal.pbio.1000479. PMID:20877715.
   PubMed Web of Science ®Google Scholar
• Gulsvik AK, Gulsvik A, Skovlund E, Thelle DS, Mowe M, Humerfelt S, Wyller TB. The association between lung function and fatal stroke in a community followed for 4 decades. J Epidemiol Community Health. 2012;66(11):1030–6. doi:10.1136/jech-2011-200312. PMID:22493479.
   PubMed Web of Science ®Google Scholar
• Truelsen T, Prescott E, Lange P, Schnohr P, Boysen G. Lung function and risk of fatal and non-fatal stroke: the copenhagen city heart study. Int J Epidemiol. 2001;30(1):145–51. doi:10.1093/ije/30.1.145. PMID:11171876.
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Shaper AG, Ebrahim S. Respiratory function and risk of stroke. Stroke. 1995;26(11):2004–10. doi:10.1161/01.STR.26.11.2004. PMID:7482639.
   PubMed Web of Science ®Google Scholar
• Rochester CL, Mohsenin V. Respiratory complications of stroke. Semin Respir Crit Care Med. 2002;23(3):248–60. doi:10.1055/s-2002-33033. PMID:16088617.
   PubMed Web of Science ®Google Scholar
• Ezeugwu VE, Olaogun M, Mbada CE, Adedoyin R. Comparative lung function performance of stroke survivors and age-matched and sex-matched controls. Physiother Res Int. 2013;18(4):212–9. doi:10.1002/pri.1547. PMID:23359511.
   PubMedGoogle Scholar
• de Almeida ICL, Clementino ACCR, Rocha EHT, Brandão DC, Dornelas de Andrade A. Effects of hemiplegy on pulmonary function and diaphragmatic dome displacement. Respiratory Physiology & Neurobiology. 2011;178(2):196–201. doi:10.1016/j.resp.2011.05.017.
   PubMed Web of Science ®Google Scholar
• Khedr EM, El Shinawy O, Khedr T, Abdel AAY, Awad EM. Assessment of corticodiaphragmatic pathway and pulmonary function in acute ischemic stroke patients. Eur J Neurol. 2000;7(5):509–16. doi:10.1046/j.1468-1331.2000.00104.x. PMID:11054135.
   PubMed Web of Science ®Google Scholar
• Jung KJ, Park JY, Hwang DW, Kim JH, Kim JH. Ultrasonographic diaphragmatic motion analysis and its correlation with pulmonary function in hemiplegic stroke patients. Ann Rehabil Med. 2014;38(1):29–37. doi:10.5535/arm.2014.38.1.29. PMID:24639923.
   PubMedGoogle Scholar
• Kang HW, Kim TO, Lee BR, Yu JY, Chi SY, Ban HJ, Oh IJ, Kim KS, Kwon YS, Kim YI, et al. Influence of diaphragmatic mobility on hypercapnia in patients with chronic obstructive pulmonary disease. J Korean Med Sci. 2011;26(9):1209–13. doi:10.3346/jkms.2011.26.9.1209. PMID:21935278.
   PubMed Web of Science ®Google Scholar
• Battaglia S, Basile M, Scichilone N, Bellia V. Prevalence of co-morbidities and severity of COPD. COPD. 2015;12(4):390–4. doi:10.3109/15412555.2014.974734. PMID:25415502.
   PubMedGoogle Scholar
• Higashimoto Y, Yamagata T, Maeda K, Honda N, Sano A, Nishiyama O, Sano H, Iwanaga T, Chiba Y, Fukuda K, et al. Influence of comorbidities on the efficacy of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Geriatr Gerontol Int. 2016;16(8):934–41. doi:10.1111/ggi.12575. PMID:26246006.
   PubMed Web of Science ®Google Scholar
• Mahishale V, Mahishale A, Patil B, Sindhuri A, Eti A. Screening for diabetes mellitus in patients with chronic obstructive pulmonary disease in tertiary care hospital in India. Niger Med J. 2015;56(2):122–5. doi:10.4103/0300-1652.150699. PMID:25838628.
   PubMedGoogle Scholar
• Hayashi T, Fukamizu S, Hojo R, Komiyama K, Tanabe Y, Tejima T, Nishizaki M, Hiraoka M, Ako J, Momomura S, et al. Prevalence and electrophysiological characteristics of typical atrial flutter in patients with atrial fibrillation and chronic obstructive pulmonary disease. Europace. 2013;15(12):1777–83. doi:10.1093/europace/eut158. PMID:23787904.
   PubMed Web of Science ®Google Scholar
• Konecny T, Park JY, Somers KR, Konecny D, Orban M, Soucek F, Parker KO, Scanlon PD, Asirvatham SJ, Brady PA, et al. Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias. Am J Cardiol. 2014;114(2):272–7. doi:10.1016/j.amjcard.2014.04.030. PMID:24878126.
   PubMed Web of Science ®Google Scholar
• Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–61. doi:10.1164/rccm.201201-0034OC. PMID:22561964.
   PubMed Web of Science ®Google Scholar
• Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–88. doi:10.2147/COPD.S49621. PMID:25210449.
   PubMed Web of Science ®Google Scholar
• Lam KB, Jordan RE, Jiang CQ, Thomas GN, Miller MR, Zhang WS, Lam TH, Cheng KK, Adab P. Airflow obstruction and metabolic syndrome: the guangzhou biobank cohort study. Eur Respir J. 2010;35(2):317–23. doi:10.1183/09031936.00024709. PMID:19574332.
   PubMed Web of Science ®Google Scholar
• Park SK, Larson JL. The relationship between physical activity and metabolic syndrome in people with chronic obstructive pulmonary disease. J Cardiovasc Nurs. 2014;29(6):499–507. doi:10.1097/JCN.0000000000000096. PMID:24165700.
   PubMed Web of Science ®Google Scholar
• Clarenbach CF, Thurnheer R, Kohler M. Vascular dysfunction in chronic obstructive pulmonary disease: current evidence and perspectives. Expert Rev Respir Med. 2012;6(1):37–43. doi:10.1586/ers.11.82. PMID:22283577.
   PubMed Web of Science ®Google Scholar
• Fimognari FL, Scarlata S, Conte ME, Incalzi RA. Mechanisms of atherothrombosis in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3(1):89–96. PMID:18488431.
   PubMedGoogle Scholar
• Dransfield MT, Huang F, Nath H, Singh SP, Bailey WC, Washko GR. CT emphysema predicts thoracic aortic calcification in smokers with and without COPD. COPD. 2010;7(6):404–10. doi:10.3109/15412555.2010.528085. PMID:21166628.
   PubMedGoogle Scholar
• Lahousse L, van den Bouwhuijsen QJ, Loth DW, Joos GF, Hofman A, Witteman JC, van der Lugt A, Brusselle GG, Stricker BH. Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the rotterdam study. Am J Respir Crit Care Med. 2013;187(1):58–64. doi:10.1164/rccm.201206-1046OC. PMID:23144329.
   PubMed Web of Science ®Google Scholar
• Maclay JD, McAllister DA, Mills NL, Paterson FP, Ludlam CA, Drost EM, Newby DE, Macnee W. Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(6):513–20. doi:10.1164/rccm.200903-0414OC. PMID:19542477.
   PubMed Web of Science ®Google Scholar
• McAllister DA, Maclay JD, Mills NL, Mair G, Miller J, Anderson D, Newby DE, Murchison JT, Macnee W. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176(12):1208–14. doi:10.1164/rccm.200707-1080OC. PMID:17885263.
   PubMed Web of Science ®Google Scholar
• Matsuoka S, Yamashiro T, Diaz A, Estepar RS, Ross JC, Silverman EK, Kobayashi Y, Dransfield MT, Bartholmai BJ, Hatabu H, et al. The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis. Acad Radiol. 2011;18(1):40–6. doi:10.1016/j.acra.2010.08.013. PMID:20947389.
   PubMed Web of Science ®Google Scholar
• Proietti M, Laroche C, Drozd M, Vijgen J, Cozma DC, Drozdz J, Maggioni AP, Boriani G, Lip GY. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: a report from the EURObservational research programme pilot survey on atrial fibrillation (EORP-AF) general registry. Am Heart J. 2016;181:83–91. doi:10.1016/j.ahj.2016.08.011. PMID:27823697.
   PubMed Web of Science ®Google Scholar
• Nadeem R, Sharieff A, Tanna S, Sidhu H, Molnar J, Nadeem A. Potential augmentation of the risk of ischemic cerebrovascular accident by chronic obstructive pulmonary disease in patients with atrial fibrillation. J Stroke Cerebrovasc Dis. 2015;24(8):1893–6. doi:10.1016/j.jstrokecerebrovasdis.2015.04.034. PMID:26142261.
   PubMed Web of Science ®Google Scholar
• Mejza F, Lamprecht B, Nizankowska-Mogilnicka E, Undas A. Arterial and venous thromboembolism in chronic obstructive pulmonary disease: from pathogenic mechanisms to prevention and treatment. Pneumonol Alergol Pol. 2015;83(6):485–94. doi:10.5603/PiAP.2015.0078. PMID:26559802.
   PubMedGoogle Scholar
• Undas A, Kaczmarek P, Sladek K, Stepien E, Skucha W, Rzeszutko M, Gorkiewicz-Kot I, Tracz W. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease: beneficial effects of simvastatin treatment. Thromb Haemost. 2009;102(6):1176–82. PMID:19967149.
   PubMed Web of Science ®Google Scholar
• Vaidyula VR, Criner GJ, Grabianowski C, Rao AK. Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease. Thromb Res. 2009;124(3):259–61. doi:10.1016/j.thromres.2008.12.030. PMID:19162305.
   PubMed Web of Science ®Google Scholar
• Ashitani J, Mukae H, Arimura Y, Matsukura S. Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease. Intern Med. 2002;41(3):181–5. doi:10.2169/internalmedicine.41.181. PMID:11929177.
   PubMed Web of Science ®Google Scholar
• Biljak VR, Pancirov D, Cepelak I, Popovic-Grle S, Stjepanovic G, Grubisic TZ. Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease. Platelets. 2011;22(6):466–70. doi:10.3109/09537104.2011.573887. PMID:21506665.
   PubMed Web of Science ®Google Scholar
• Wang RT, Li JY, Cao ZG, Li Y. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease. Respirology. 2013;18(8):1244–8. doi:10.1111/resp.12143. PMID:23786593.
   PubMed Web of Science ®Google Scholar
• Lin C-S, Shih C-C, Yeh C-C, Hu C-J, Chung C-L, Chen T-L, Liao C-C. Risk of stroke and post-stroke adverse events in patients with exacerbations of chronic obstructive pulmonary disease. PLoS ONE. 2017;12(1):e0169429. doi:10.1371/journal.pone.0169429. PMID:28060955.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137(5):1091–7. doi:10.1378/chest.09-2029. PMID:20022970.
   PubMed Web of Science ®Google Scholar
• Windsor C, Herrett E, Smeeth L, Quint JK. No association between exacerbation frequency and stroke in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:217–25. PMID:26893553.
   PubMed Web of Science ®Google Scholar
• Bateman LM, Li C-S, Seyal M. Ictal hypoxemia in localization-related epilepsy: analysis of incidence, severity and risk factors. Brain. 2008;131(12):3239–45. doi:10.1093/brain/awn277. PMID:18952672.
   PubMed Web of Science ®Google Scholar
• Corlateanu A, Botnaru V, Mathioudakis AG, Sircu V, Siafakas N. Overlap syndrome of chronic obstructive pulmonary disease and obstructive sleep apnea: a two-faced janus. Curr Respir Med Rev. 2015;11(4):308–13. doi:10.2174/1573398X11666150915213406.
   Web of Science ®Google Scholar
• Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke. 2005;36(12):2756–63. doi:10.1161/01.STR.0000190056.76543.eb. PMID:16269630.
   PubMed Web of Science ®Google Scholar
• Satou Y, Oguro H, Murakami Y, Onoda K, Mitaki S, Hamada C, Mizuhara R, Yamaguchi S. Gastroesophageal reflux during enteral feeding in stroke patients: a 24-hour esophageal pH-monitoring study. J Stroke Cerebrovasc Dis. 2013;22(3):185–9. doi:10.1016/j.jstrokecerebrovasdis.2011.07.008. PMID:21852155.
   PubMed Web of Science ®Google Scholar
• Liang B, Wang M, Yi Q, Feng Y. Association of gastroesophageal reflux disease risk with exacerbations of chronic obstructive pulmonary disease. Dis Esophagus. 2013;26(6):557–60. doi:10.1111/dote.12014. PMID:23301861.
   PubMed Web of Science ®Google Scholar
• Ho SW, Hsieh MJ, Yang SF, Yeh YT, Wang YH, Yeh CB. Risk of stroke-associated pneumonia with acid-suppressive drugs: a population-based cohort study. Medicine (Baltimore). 2015;94(29):e1227. doi:10.1097/MD.0000000000001227. PMID:26200649.
   PubMed Web of Science ®Google Scholar
• Arai N, Nakamizo T, Ihara H, Koide T, Nakamura A, Tabuse M, Miyazaki H. Histamine H2-blocker and proton pump inhibitor use and the risk of pneumonia in acute stroke: a retrospective analysis on susceptible patients. PLoS One. 2017;12(1):e0169300. doi:10.1371/journal.pone.0169300. PMID:28085910.
   PubMed Web of Science ®Google Scholar
• Cascini S, Kirchmayer U, Belleudi V, Bauleo L, Pistelli R, Di Martino M, Formoso G, Davoli M, Agabiti N. Inhaled corticosteroid use in chronic obstructive pulmonary disease and risk of pneumonia: a nested case-control population-based study in Lazio (Italy)-the OUTPUL study. COPD. 2017;14(3):311–7. doi:10.1080/15412555.2016.1254172. PMID:28406337.
   PubMedGoogle Scholar
• Huang CW, Saposnik G, Fang J, Steven DA, Burneo JG. Influence of seizures on stroke outcomes: a large multicenter study. Neurology. 2014;82(9):768–76. doi:10.1212/WNL.0000000000000166. PMID:24489133.
   PubMed Web of Science ®Google Scholar
• Hoffmann S, Harms H, Ulm L, Nabavi DG, Mackert BM, Schmehl I, Jungehulsing GJ, Montaner J, Bustamante A, Hermans M, et al. Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia – The PREDICT study. J Cereb Blood Flow Metab. 2017;37(12):3671–82.
   PubMed Web of Science ®Google Scholar
• Park GW, Kim SK, Lee CH, Kim CR, Jeong HJ, Kim DK. Effect of chronic obstructive pulmonary disease on swallowing function in stroke patients. Ann Rehabil Med. 2015;39(2):218–25. doi:10.5535/arm.2015.39.2.218. PMID:25932418.
   PubMedGoogle Scholar
• Hsieh SJ, Zhuo H, Benowitz NL, Thompson BT, Liu KD, Matthay MA, Calfee CS. Prevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome. Crit Care Med. 2014;42(9):2058–68. doi:10.1097/CCM.0000000000000418. PMID:24942512.
   PubMed Web of Science ®Google Scholar
• Calfee CS, Matthay MA, Kangelaris KN, Siew ED, Janz DR, Bernard GR, May AK, Jacob P, Havel C, Benowitz NL, et al. Cigarette smoke exposure and the acute respiratory distress syndrome. Crit Care Med. 2015;43(9):1790–7. doi:10.1097/CCM.0000000000001089. PMID:26010690.
   PubMed Web of Science ®Google Scholar
• Seethala RR, Hou PC, Aisiku IP, Frendl G, Park PK, Mikkelsen ME, Chang SY, Gajic O, Sevransky J. Early risk factors and the role of fluid administration in developing acute respiratory distress syndrome in septic patients. Ann Intensive Care. 2017;7(1):11. doi:10.1186/s13613-017-0233-1. PMID:28116595.
   PubMedGoogle Scholar
• Zhao JN, Liu Y, Li HC. Aspiration-related acute respiratory distress syndrome in acute stroke patient. PLoS One. 2015;10(3):e0118682. doi:10.1371/journal.pone.0118682. PMID:25790377.
   PubMed Web of Science ®Google Scholar
• Corlateanu A, Montanari G, Mathioudakis AG, Botnaru V, Siafakas N. Management of Stable COPD: An Update. Curr Respir Med Rev. 2013;9(6):352–9. doi:10.2174/1573398X10666140222001646.
   Google Scholar
• Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax. 2006;61(1):23–8. doi:10.1136/thx.2005.042200. PMID:16143583.
   PubMed Web of Science ®Google Scholar
• He Z, Chen Y, Chen P, Wu G, Cai S. Local inflammation occurs before systemic inflammation in patients with COPD. Respirology. 2010;15(3):478–84. doi:10.1111/j.1440-1843.2010.01709.x. PMID:20210891.
   PubMed Web of Science ®Google Scholar
• Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS, et al. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(11):1207–14. doi:10.1164/rccm.200709-1356OC. PMID:18310480.
   PubMed Web of Science ®Google Scholar
• Mathioudakis AG, Chatzimavridou-Grigoriadou V, Evangelopoulou E, Mathioudakis GA, Siafakas NM. Comparative mortality risk of tiotropium administered via handihaler or respimat in COPD patients: are they equivalent? Pulm Pharmacol Ther. 2014;28(2):91–7. doi:10.1016/j.pupt.2014.04.009. PMID:24846455.
   PubMed Web of Science ®Google Scholar
• Mathioudakis AG, Mastoris I, Chatzimavridou-Grigoriadou V, Mathioudakis GA. The risk of tachyarrhythmias in patients with moderate-to-severe chronic kidney disease receiving tiotropium bromide. Int J Cardiol. 197:105–6. doi:10.1016/j.ijcard.2015.06.051. PMID:26142194.
   PubMed Web of Science ®Google Scholar
• Wilchesky M, Ernst P, Brophy JM, Platt RW, Suissa S. Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger quebec cohort. Chest. 2012;142(2):305–11. doi:10.1378/chest.11-1597. PMID:22871756.
   PubMed Web of Science ®Google Scholar
• Wilchesky M, Ernst P, Brophy JM, Platt RW, Suissa S. Bronchodilator use and the risk of arrhythmia in COPD: part 1: saskatchewan cohort study. Chest. 2012;142(2):298–304. doi:10.1378/chest.10-2499. PMID:22871755.
   PubMed Web of Science ®Google Scholar
• Lin H-W, Chung C-L, Lin YS, Yu C-M, Lee C-N, Bien M-Y. Inhaled pharmacotherapy and stroke risk in patients with chronic obstructive pulmonary disease: a nationwide population based study using two-stage approach. PLoS ONE. 2015;10(7):e0130102. doi:10.1371/journal.pone.0130102. PMID:26158649.
   PubMed Web of Science ®Google Scholar
• Wang MT, Tsai CL, Lo YW, Liou JT, Lee WJ, Lai IC. Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: a population-based nested case-control study. Int J Cardiol. 2012;158(2):279–84. doi:10.1016/j.ijcard.2012.02.012. PMID:22386700.
   PubMed Web of Science ®Google Scholar
• Singh S, Loke YK, Enright P, Furberg CD. Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Postgrad Med J. 2014;90(1062):205–7. doi:10.1136/postgradmedj-2011-201275rep. PMID:24643260.
   PubMed Web of Science ®Google Scholar
• Mathioudakis AG, Kanavidis P, Chatzimavridou-Grigoriadou V, Gialmanidis IP, Amanetopoulou SG, Christopoulou E, Evangelopoulou E, Mathioudakis GA. Tiotropium HandiHaler improves the survival of patients with COPD: a systematic review and meta-analysis. J Aerosol Med Pulm Drug Deliv. 2013;27(1):43–50. doi:10.1089/jamp.2012.1012. PMID:23521168.
   PubMed Web of Science ®Google Scholar
• Verhamme KM, Afonso AS, van Noord C, Haag MD, Koudstaal PJ, Brusselle GG, Sturkenboom MC. Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD. Pulm Pharmacol Ther. 2012;25(1):19–26. doi:10.1016/j.pupt.2011.10.004. PMID:22051450.
   PubMed Web of Science ®Google Scholar
• Oliveira MF, Rodrigues MK, Treptow E, Cunha TM, Ferreira EM, Neder JA. Effects of oxygen supplementation on cerebral oxygenation during exercise in chronic obstructive pulmonary disease patients not entitled to long-term oxygen therapy. Clin Physiol Funct Imaging. 2012;32(1):52–8. doi:10.1111/j.1475-097X.2011.01054.x. PMID:22152079.
   PubMed Web of Science ®Google Scholar
• Rodrigues MK, Oliveira MF, Soares A, Treptow E, Neder JA. Additive effects of non-invasive ventilation to hyperoxia on cerebral oxygenation in COPD patients with exercise-related O2 desaturation. Clin Physiol Funct Imaging. 2013;33(4):274–81. doi:10.1111/cpf.12024. PMID:23692616.
   PubMed Web of Science ®Google Scholar
• Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775–89. doi:10.1056/NEJMoa063070. PMID:17314337.
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, Thach C, Fogel R, Patalano F, Vogelmeier CF. Indacaterol–glycopyrronium versus salmeterol–fluticasone for COPD. N Engl J Med. 2016;374(23):2222–34. doi:10.1056/NEJMoa1516385. PMID:27181606.
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–54. doi:10.1056/NEJMoa0805800. PMID:18836213.
   PubMed Web of Science ®Google Scholar
• Singh D, Papi A, Corradi M, Pavlišová I, Montagna I, Francisco C, Cohuet G, Vezzoli S, Scuri M, Vestbo J. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting b-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial. The Lancet. 2016;388(10048):963–73. doi:10.1016/S0140-6736(16)31354-X.
   PubMed Web of Science ®Google Scholar
• Harrison MT, Short P, Williamson PA, Singanayagam A, Chalmers JD, Schembri S. Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy? Thorax. 2014;69(7):609–15. doi:10.1136/thoraxjnl-2013-203996. PMID:24743560.
   PubMed Web of Science ®Google Scholar
• Ekstrom MP, Wagner P, Strom KE. Trends in cause-specific mortality in oxygen-dependent chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(8):1032–6. doi:10.1164/rccm.201010-1704OC. PMID:21216882.
   PubMed Web of Science ®Google Scholar
• Ekstrom MP, Hermansson AB, Strom KE. Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):715–20. doi:10.1164/rccm.201208-1565OC. PMID:23328521.
   PubMed Web of Science ®Google Scholar
• Wang MT, Lo YW, Tsai CL, Chang LC, Malone DC, Chu CL, Liou JT. Statin use and risk of COPD exacerbation requiring hospitalization. Am J Med. 2013;126(7):598–606 e2. doi:10.1016/j.amjmed.2013.01.036. PMID:23684060.
   PubMed Web of Science ®Google Scholar
• Lahousse L, Loth DW, Joos GF, Hofman A, Leufkens HG, Brusselle GG, Stricker BH. Statins, systemic inflammation and risk of death in COPD: the Rotterdam study. Pulm Pharmacol Ther. 2013;26(2):212–7. doi:10.1016/j.pupt.2012.10.008. PMID:23142156.
   PubMed Web of Science ®Google Scholar
• Cao C, Wu Y, Xu Z, Lv D, Zhang C, Lai T, Li W, Shen H. The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: a systematic review and meta-analysis of observational research. Sci Rep. 2015;5:16461. doi:10.1038/srep16461. PMID:26553965.
   PubMed Web of Science ®Google Scholar